Suchergebnisse - "Antibodies, Viral"

PubPharm (6.423)

21

The importance of using WHO International Standards to harmonise SARS-CoV-2 serological assays

enthalten in: The Lancet. Microbe | 2024

von Hempel, H. | Page, M. | Kemp, T. | +3

22

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

enthalten in: JCI insight | 2024

von Park, H. | Yin, A. | Barranta, C. | +78

UpdateOf: medRxiv. 2023 Dec 15;:. - PMID 37131659

23

The immune response to SARS-CoV-2 in people with HIV

enthalten in: Cellular & molecular immunology | 2024

von Höft, M. | Burgers, W. | Riou, C.

24

The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients : A Multi-Center Randomized Controlled Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Schuster, J. | Hamdan, L. | Dulek, D. | +40

25

Ipsilateral immunization after a prior SARS-CoV-2 mRNA vaccination elicits superior B cell responses compared to contralateral immunization

enthalten in: Cell reports | 2024

von Jiang, W. | Maldeney, A. | Yuan, X. | +3

26

Anti-neuraminidase immunity in the combat against influenza

enthalten in: Expert review of vaccines | 2024

von Zhang, X. | Ross, T.

27

Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample

enthalten in: PloS one | 2024

von Yaseen, A. | DeSantis, S. | Sabharwal, R. | +13

28

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies

enthalten in: Frontiers in immunology | 2024

von Ankunda, V. | Katende, J. | Oluka, G. | +16

29

Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

enthalten in: Frontiers in immunology | 2024

von Serwanga, J. | Ankunda, V. | Katende, J. | +16

30

Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice

enthalten in: Frontiers in immunology | 2024

von Jangra, S. | Lamoot, A. | Singh, G. | +6